Secondary Hyperoxaluria: Clinical Trials

1 trial for Secondary Hyperoxaluria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Secondary Hyperoxaluria: new trials by email Literature Review of Secondary Hyperoxaluria trials Research Report on Secondary Hyperoxaluria

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lanthanum Carbonate (FosrenolĀ®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis
Lanthanum Carbonate - Secondary Hyperoxaluria, Nephrolithiasis
Phase 3CompletedUniversitair Ziekenhuis Brussel542017-08-182026-08-10

Narrower conditions

Hyperoxaluria (1)  ·  Nephrolithiasis (1)  ·  Urolithiasis (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

lanthanum carbonate (1)

Sponsors

Universitair Ziekenhuis Brussel (1)

Countries

Belgium (1)

Top investigators

Christian Tielemans, MD, PhD (1)